Tag Archives: Early Embryo Viability Assessment

Merck receives global marketing and commercialization rights for Progyny’s Early Embryo Viability Assessment (Eeva®) software

Merck obtains global marketing and commercialization rights for the innovative Progyny Eeva® software offering, aiming to provide customers worldwide with innovative fertility technologies solutions This new agreement builds on the successful relationship between both leaders in fertility technologies, first established … Read the full press release